Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Benzenepropanoic acid, 3-bromo-.alpha.-oxo-, also known as 3-(3-bromophenyl)-2-oxopropanoic acid, is an organic compound with a unique chemical structure that features a bromo-phenyl group attached to a propanoic acid backbone. Benzenepropanoic acid, 3-broMo-.alpha.-oxopossesses a carbonyl group and exhibits acidic properties, making it a versatile building block in the synthesis of various pharmaceutical agents.

207910-90-5

Post Buying Request

207910-90-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

207910-90-5 Usage

Uses

Used in Pharmaceutical Industry:
Benzenepropanoic acid, 3-bromo-.alpha.-oxo-, is used as a key intermediate in the synthesis of carbonic anhydrase XII inhibitors for chemotherapeutic drugs. Carbonic anhydrase XII is an enzyme that plays a crucial role in tumor growth and metastasis, and its inhibition can lead to the suppression of these processes. Benzenepropanoic acid, 3-broMo-.alpha.-oxo-'s unique structure allows for the development of targeted therapies with improved efficacy and reduced side effects in cancer treatment.

Check Digit Verification of cas no

The CAS Registry Mumber 207910-90-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,7,9,1 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 207910-90:
(8*2)+(7*0)+(6*7)+(5*9)+(4*1)+(3*0)+(2*9)+(1*0)=125
125 % 10 = 5
So 207910-90-5 is a valid CAS Registry Number.

207910-90-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(3-Bromophenyl)-2-oxopropanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:207910-90-5 SDS

207910-90-5Relevant articles and documents

IMMUNOMODULATOR ANTIBODY DRUG CONJUGATES AND USES THEREOF

-

Paragraph 00529-00530; 00558-00559, (2020/12/30)

Provided herein are compounds, trifunctional antibody products thereof, and methods and pharmaceutical compositions for use in treatment of inflammatory and/or proliferative diseases.

Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma

Mujumdar, Prashant,Kopecka, Joanna,Bua, Silvia,Supuran, Claudiu T.,Riganti, Chiara,Poulsen, Sally-Ann

, p. 4174 - 4192 (2019/05/01)

The natural product primary sulfonamide, psammaplin C (1), when used in combination with clinically used chemotherapeutic drugs, including temozolomide, reverses multidrug resistance and increases survival in glioblastoma, a highly aggressive primary brain tumor. We showed previously that the mechanism of action of 1 is novel, acting to indirectly interfere with P-glycoprotein drug efflux activity as a consequence of carbonic anhydrase XII (CA XII) inhibition. To build structure-activity relationships, 45 derivatives of 1 were designed, synthesized, and evaluated against a panel of CA isoforms. Compound 55 was identified as a potent inhibitor of CA XII (Ki = 0.56 nM) and was investigated in vitro and in vivo using samples from glioblastoma patients. The results strengthen the possibility that co-therapy of temozolomide with a CA XII inhibitor may more effectively treat glioblastoma by suppressing an important temozolomide resistance mechanism.

HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY

-

Paragraph 00290-00291, (2016/08/23)

Provided herein are hemiasterlin derivatives, conjugates thereof, compositions comprising the derivatives or conjugates thereof, methods of producing the derivatives and conjugates thereof, and methods of using the derivatives, conjugates, and compositions for the treatment of cell proliferation. The derivatives, conjugates, and compositions are useful in methods of treatment and prevention of cell proliferation and cancer, methods of detection of cell proliferation and cancer, and methods of diagnosis of cell proliferation and cancer. In an embodiment, the hemiasterlin derivatives are according to Formula 1000: or a pharmaceutically acceptable salt, solvate, or tautomer thereof, wherein Ar, L, W1, W4, W5, SG, and R are as described herein.

Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: Modification of the a segment

Yamashita, Ayako,Norton, Emily B.,Kaplan, Joshua A.,Niu, Chuan,Loganzo, Frank,Hernandez, Richard,Beyer, Carl F.,Annable, Tami,Musto, Sylvia,Discafani, Carolyn,Zask, Arie,Ayral-Kaloustian, Semiramis

, p. 5317 - 5322 (2007/10/03)

Analogs of HTI-286 (1), containing various aromatic rings in the A segment, were synthesized as potential inhibitors of tubulin polymerization, and the structure-activity relationships related to stereo- and regio-chemical effects of substituents on the a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 207910-90-5